Polypharmacy in Psychiatry Practice, Volume I

Part I. Polypharmacy Treatment Strategies

1. Multiple Psychiatric Medications Use in Psychiatry: How Rational Can It Be?
Ahsan Y. Khan, Sheldon H. Preskorn

2. Receptor Binding Targets for Antipsychotic Efficacy
Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand

3. Drug Interactions and Polypharmacy
Jessica L. Gören, Ashley Tewksbury

4. Preclinical and Clinical Investigation of Antipsychotic Polypharmacy: What Is the Evidence?
Dimitrios Kontis, Eirini Theochari

5. Should High Dose or Very Long-Term Antipsychotic Monotherapy Be Considered Before Antipsychotic Polypharmacy?
Stephen M. Stahl, Debbi A. Morrissette

6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt
Joachim G. Witzel

Part II. Augmentation Strategies

7. Antipsychotic Treatment Within a Naturalistic Trial—How Are We Treating Schizophrenia Patients in the “Real-World”?
Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller, Michael Riedel

8. A Multi-Target Drug Treatment in Schizophrenia and Schizoaffective Disorder Using Adjunctive Agents with Non-D2 Mechanisms of Action
Michael S. Ritsner

9. Antidepressants in Schizophrenia: A Place for Them?
Viacheslav Terevnikov, Grigori Joffe

10. Stress Sensitization and Anticonvulsant Medication in Psychiatric Patients
Petr Bob

11. Multiple Medication Use in Somatic Symptom Disorders: From Augmentation to Diminution Strategies
Adrian P. Mundt

Keywords: Biomedicine, Biomedicine general, Psychiatry, Pharmacy, Clinical Psychology, Medical Education, Psychopharmacology